-
Mashup Score: 17
(UPDATED) Pooled data from three NUDGE-FLU trials show targeted messaging about CV benefits is helpful in these high-risk patients.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 2
The prevalence of obesity and overweight is extraordinarily high. Unsurprisingly, deaths related to obesity are on the rise, too.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
The Global Burden of Disease collaboration data highlights the ongoing obesity epidemic in the US, with projections indicating that by 2050 nearly 213 million adults will have overweight or obesity. Read the full story at TCTMD: https://t.co/hw9oh1w6B0 https://t.co/nxNoTi7214
-
-
Mashup Score: 1
(UPDATED) The mixed, counterintuitive results hinder trial interpretation, but along with ARREST-AF, experts still see actionable results.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
“We're learning that maybe we have more influence over our patients than we sometimes think,” explains Mina Chung (@EP_mom1) at #AHA24. TRIM-AF data presented last week found that lifestyle and risk factor management does impact AF burden over time. https://t.co/IuAKjTP2sp https://t.co/luwpQv5sFz
-
-
Mashup Score: 6
Britton Scheuermann, MS, shares how researchers validated the new tool’s ability to predict 10-year risk of mortality.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
A recent study found that the @AHAscience PREVENT equations accurately predict 10-year CVD mortality risk. Check out this #QuickTakes with @BrittonSherm for his explanation of the findings! https://t.co/5DA9ctNRXj https://t.co/jP5fkj20zi
-
-
Mashup Score: 2Talking Sex: CVD Patients Want to Hear More From Clinicians - 5 day(s) ago
In the Swedish survey, many patients said their sexual health was impaired, but few got the information they wanted.
Source: www.tctmd.comCategories: General Medicine News, Cardiology News and JournTweet-
A recent study finds that 78% of CVD surveyed patients wanted information on sexual health, but only 5% received it. The findings, presented at #AHA24, reveal the need for a better incorporation of sexual health into treatment plans, explains @DrJMieres. https://t.co/VBUv9CSBu0 https://t.co/lzHtS3FF7s
-
-
Mashup Score: 1
Though the results aren’t definitive, it’s not premature to suggest high-risk individuals take shelter on very hot days.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
Data presented by @Barrak1 at #AHA24 sheds light on the possible link between environmental exposures and arrhythmias. Results reveal that extreme temperatures appear to cause an increased risk of atrial arrhythmias for IED patients. https://t.co/cTIHBIGl3o https://t.co/ROpadxNYOi
-
-
Mashup Score: 25AI Poised to Change the Landscape of Echocardiography - 6 day(s) ago
Two studies presented at AHA show the capacity of AI to improve sonographer accuracy, consistency, and workflow.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
“Echocardiography is the ideal place to use AI,” comments @David_Ouyang. At #AHA24, two new studies added further evidence in support of AI’s potential to transform the echocardiology landscape. For all the details on the study presentations: https://t.co/VPKSZ9PZah https://t.co/WkDvaXk3Lh
-
-
Mashup Score: 11
Although some of the trial’s methodology was critiqued, the results provide fodder for shared decision-making discussions.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
Oussama Wazni (@omwazni) shares findings from the OPTION trial at #AHA24 indicating that LAAO could be an alternative to oral anticoagulation for stroke prevention in certain patients undergoing catheter ablation. Full story at TCTMD: https://t.co/2PHYvNzFHj https://t.co/jOPZULsjym
-
-
Mashup Score: 5
In positive early data from the RCT, sacubitril/valsartan given over 24 weeks reduced signs of heart damage in cancer patients.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
Sacubitril/valsartan given over 24 weeks is found to minimize signs of heart damage for cancer patients, according the SARAH trial results presented at #AHA24. Investigator @MarcelyGBonatto says the next step is further testing with longer follow-up. https://t.co/AmG5SB4B4q https://t.co/aFlxZcyybu
-
-
Mashup Score: 4
(UPDATED) Part 2 of this 7,000-patient trial suffered from discontinuations and low event rates: still, early MRAs did not impact CV events.
Source: www.tctmd.comCategories: General Medicine News, CardiologistsTweet-
CLEAR SYNERGY results find that spironolactone given to patients after an acute MI had no impact on CV related death or other cardiovascular events. With comments & discussion from @SanjitSJolly, @Drroxmehran, @MarcBonaca, @AndrewJSauer, & @gabrielsteg: https://t.co/bA4OEaBiPF https://t.co/FehIHM2KUO
-
Analysis of the NUDGE-FLU trial program finds that email reminders can be effective in encouraging patients with a history of acute MI to get their annual flu shot. Read the full story, featuring @ankeetbhatt, @orlyvardeny, @dmljmd, @mmadjid, and more: https://t.co/ZJ9U3iWJeX… https://t.co/KFwjWqs3Ea https://t.co/Jdp2PuThNj